IRWD
IRONWOOD PHARMACEUTICALS INC
- Latest sale
- $28k
- Nov 16 · No plan
- Form 4 sales
- 257
- On record
- Form 144 notices
- 14
- Proposed sales
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- 1 Form 4 saleNo planFeb 24 2026
Sold 198,283 shares at $3.73 ($740k)
MCCOURT Thomas A, Chief Executive Officer
No 10b5-1 planSold 11.8% of holdings ($6.3M position)1.5M shares left2.9x usual sizeFiling
- 2 Form 4 saleUnusualFeb 24 same day
Sold 21,526 shares at $3.73 ($80k)
Gaskins Tammi L, Chief Commercial Officer
No 10b5-1 planSold 9.1% of holdings ($878k position)213,738 shares left8.4x usual sizeFiling
- 3 Form 4 saleNo planFeb 24 same day
Sold 36,492 shares at $3.73 ($136k)
John Minardo, Chief Legal Officer
No 10b5-1 planSold 9.1% of holdings ($1.5M position)363,886 shares left2.7x usual sizeFiling
- 4 Form 4 saleNo planFeb 24 same day
Sold 21,944 shares at $3.73 ($82k)
Martini Gregory S., Chief Financial Officer
No 10b5-1 planSold 12% of holdings ($681k position)160,601 shares leftFiling
- 5 Form 4 saleUnusualMar 17 +21 days
Sold 6.7M shares at $3.05 ($20.5M)
Denner Alexander J, Director
No 10b5-1 planSold 42.3% of holdings ($48.6M position)9.2M shares leftFirst sale on recordFiling
- 6 Form 4 saleRoutineJun 16 +91 days
Sold 21,571 shares at $3.73 ($80k)
McHugh Julie, Director
10b5-1 planSold 7.9% of holdings ($1M position)250,749 shares leftFirst sale on recordFiling
- 7 Form 4 saleUnusualJul 7 +21 days
Sold 127,890 shares at $4.52 ($578k)
Silver Ronald, PFO & PAO
10b5-1 planSold 29% of holdings ($2M position)313,680 shares left10.6x usual sizeFiling
- 8 Form 4 saleNo planNov 16 +132 days
Sold 5,919 shares at $4.81 ($28k)
Gaskins Tammi L, Chief Commercial Officer
No 10b5-1 planSold 1.7% of holdings ($1.7M position)344,431 shares left1.4x usual sizeFiling
Every transaction
Loading transactions…
Sales, notices and lockups (271)
Export watchlist as CSV| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | Gaskins Tammi L | Chief Commercial Officer | Form 4 sale | 5,919 | $28k | 1.7% | No plan | SEC |
| Jul 7, 2026 | Silver Ronald | PFO & PAO | Form 4 sale | 127,890 | $578k | 29.0% | Unusual | SEC |
| Jun 16, 2026 | McHugh Julie | Director | Form 4 sale | 21,571 | $80k | 7.9% | Routine | SEC |
| Mar 17, 2026 | Denner Alexander J | Director | Form 4 sale | 6.7M | $20.5M | 42.3% | Unusual | SEC |
| Feb 24, 2026 | Martini Gregory S. | Chief Financial Officer | Form 4 sale | 21,944 | $82k | 12.0% | No plan | SEC |
| Feb 24, 2026 | John Minardo | Chief Legal Officer | Form 4 sale | 36,492 | $136k | 9.1% | No plan | SEC |
| Feb 24, 2026 | Gaskins Tammi L | Chief Commercial Officer | Form 4 sale | 21,526 | $80k | 9.1% | Unusual | SEC |
| Feb 24, 2026 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 198,283 | $740k | 11.8% | No plan | SEC |
| Feb 24, 2026 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 24,173 | $90k | 8.7% | Unusual | SEC |
| Feb 23, 2026 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Form 4 sale | 15,570 | $59k | 2.8% | No plan | SEC |
| Jan 5, 2026 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 35,416 | $163k | 11.3% | Unusual | SEC |
| Nov 17, 2025 | Gaskins Tammi L | Chief Commercial Officer | Form 4 sale | 6,016 | $20k | 2.5% | No plan | SEC |
| Aug 11, 2025 | Gaskins Tammi L | Chief Commercial Officer | Form 4 sale | 1,316 | $1k | 0.5% | No plan | SEC |
| Aug 11, 2025 | John Minardo | Chief Legal Officer | Form 4 sale | 7,754 | $7k | 1.9% | No plan | SEC |
| Aug 11, 2025 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 2,846 | $2k | 1.0% | No plan | SEC |
| Aug 11, 2025 | Martini Gregory S. | Chief Financial Officer | Form 4 sale | 1,265 | $1k | 0.7% | No plan | SEC |
| May 16, 2025 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 13,353 | $8k | 1.2% | No plan | SEC |
| May 16, 2025 | Gaskins Tammi L | Chief Commercial Officer | Form 4 sale | 2,563 | $1k | 1.0% | No plan | SEC |
| Feb 10, 2025 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 139,064 | $245k | 10.7% | Unusual | SEC |
| Feb 10, 2025 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 12,048 | $21k | 4.1% | No plan | SEC |
| Feb 10, 2025 | Shetzline Michael | SVP, CMO, Head-Res&Drug | Form 4 sale | 41,269 | $73k | 6.9% | No plan | SEC |
| Feb 10, 2025 | John Minardo | Chief Legal Officer | Form 4 sale | 38,938 | $69k | 8.7% | Unusual | SEC |
| Feb 10, 2025 | Martini Gregory S. | Chief Financial Officer | Form 4 sale | 12,052 | $21k | 6.2% | No plan | SEC |
| Nov 18, 2024 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 5,360 | $22k | 1.8% | No plan | SEC |
| Nov 18, 2024 | Emany Sravan Kumar | SVP, COO and CFO | Form 4 sale | 11,001 | $45k | 3.4% | No plan | SEC |
| Aug 12, 2024 | John Minardo | Chief Legal Officer | Form 4 sale | 9,910 | $42k | 3.4% | No plan | SEC |
| Aug 12, 2024 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 3,107 | $13k | 1.9% | No plan | SEC |
| Jun 10, 2024 | McHugh Julie | Director | Form 4 sale | 22,766 | $143k | 14.0% | Routine | SEC |
| Jun 7, 2024 | Moukheibir Catherine | Director | Form 4 sale | 80,000 | $518k | 62.2% | Unusual | SEC |
| May 20, 2024 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 67,618 | $436k | 5.6% | No plan | SEC |
| May 20, 2024 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 22,725 | $147k | 7.3% | Unusual | SEC |
| May 20, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 16,128 | $104k | 3.8% | No plan | SEC |
| May 20, 2024 | John Minardo | Chief Legal Officer | Form 4 sale | 17,404 | $112k | 5.6% | No plan | SEC |
| Feb 12, 2024 | John Minardo | Chief Legal Officer | Form 4 sale | 47,380 | $722k | 17.4% | Unusual | SEC |
| Feb 12, 2024 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 38,618 | $589k | 10.2% | No plan | SEC |
| Feb 12, 2024 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 7,908 | $121k | 5.6% | Unusual | SEC |
| Feb 12, 2024 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 9,846 | $150k | 4.5% | No plan | SEC |
| Feb 12, 2024 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 177,164 | $2.7M | 17.5% | Unusual | SEC |
| Feb 9, 2024 | Shetzline Michael | Officer | Form 144 notice | 45,181 | $673k | Notice | SEC | |
| Feb 9, 2024 | John Minardo | Officer | Form 144 notice | 55,429 | $826k | Notice | SEC | |
| Feb 9, 2024 | MCCOURT Thomas A | Officer, Director | Form 144 notice | 207,264 | $3.1M | Notice | SEC | |
| Feb 9, 2024 | Davis Andrew | Officer | Form 144 notice | 11,519 | $172k | Notice | SEC | |
| Dec 14, 2023 | Kessler Marla L | Director | Form 4 sale | 9,926 | $111k | 9.3% | Routine | SEC |
| Dec 14, 2023 | Kessler Marla L | Director | Form 144 notice | 9,926 | $111k | Notice | SEC | |
| Nov 20, 2023 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 3,287 | $32k | 1.5% | No plan | SEC |
| Nov 17, 2023 | Davis Andrew | Officer | Form 144 notice | 3,859 | $36k | Notice | SEC | |
| Aug 14, 2023 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 1,976 | $20k | 1.5% | No plan | SEC |
| Aug 14, 2023 | John Minardo | Chief Legal Officer | Form 4 sale | 7,045 | $71k | 3.5% | No plan | SEC |
| Aug 11, 2023 | John Minardo | Officer | Form 144 notice | 8,281 | $80k | Notice | SEC | |
| Aug 1, 2023 | Rickard Jason | Officer | Form 144 notice | 30,000 | $335k | Notice | SEC | |
| Jun 7, 2023 | Rickard Jason | Officer | Form 144 notice | 40,309 | $448k | Notice | SEC | |
| May 30, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 26,632 | $285k | 3.4% | Routine | SEC |
| May 30, 2023 | MCCOURT Thomas A | Officer, Director | Form 144 notice | 26,632 | $285k | Notice | SEC | |
| May 22, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 36,000 | $364k | 4.4% | No plan | SEC |
| May 22, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 10,324 | $104k | 3.1% | No plan | SEC |
| May 22, 2023 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 6,305 | $64k | 2.8% | No plan | SEC |
| May 19, 2023 | MCCOURT Thomas A | Officer, Director | Form 144 notice | 40,907 | $418k | Notice | SEC | |
| May 19, 2023 | Davis Andrew | Officer | Form 144 notice | 7,165 | $73k | Notice | SEC | |
| May 19, 2023 | Shetzline Michael | Officer | Form 144 notice | 11,731 | $120k | Notice | SEC | |
| May 8, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 21,148 | $225k | 2.5% | No plan | SEC |
| May 8, 2023 | MCCOURT Thomas A | Officer, Director | Form 144 notice | 21,148 | $225k | Notice | SEC | |
| Mar 27, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 46,129 | $492k | 5.2% | No plan | SEC |
| Mar 3, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 33,756 | $379k | 5.0% | Plan not stated | SEC |
| Feb 28, 2023 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 5,978 | $68k | 5.7% | Unusual | SEC |
| Feb 28, 2023 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 34,175 | $388k | 9.3% | Plan not stated | SEC |
| Feb 28, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 61,231 | $696k | 8.2% | Plan not stated | SEC |
| Feb 28, 2023 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 19,322 | $219k | 6.9% | Plan not stated | SEC |
| Feb 28, 2023 | John Minardo | Chief Legal Officer | Form 4 sale | 6,697 | $76k | 4.8% | Plan not stated | SEC |
| Feb 28, 2023 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 3,573 | $41k | 2.3% | Plan not stated | SEC |
| Jan 5, 2023 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 110,962 | $1.3M | 13.5% | Unusual | SEC |
| Dec 14, 2022 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 27,000 | $335k | 7.2% | Plan not stated | SEC |
| Nov 21, 2022 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 682 | $8k | 0.6% | Plan not stated | SEC |
| Nov 21, 2022 | Emany Sravan Kumar | SVP, Chief Financial Officer | Form 4 sale | 6,578 | $76k | 7.7% | Plan not stated | SEC |
| Nov 21, 2022 | Davis Andrew | SVP, Chief Business Officer | Form 4 sale | 3,335 | $39k | 2.1% | Plan not stated | SEC |
| Oct 3, 2022 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 18,899 | $197k | 2.6% | Plan not stated | SEC |
| Sep 1, 2022 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 26,446 | $282k | 3.5% | Plan not stated | SEC |
| Aug 15, 2022 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 2,014 | $24k | 1.9% | Plan not stated | SEC |
| Aug 15, 2022 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 994 | $12k | 0.3% | Plan not stated | SEC |
| Aug 15, 2022 | John Minardo | Chief Legal Officer | Form 4 sale | 7,330 | $86k | 5.0% | Plan not stated | SEC |
| Aug 11, 2022 | Currie Mark G | Director | Form 4 sale | 70,000 | $825k | 11.8% | Plan not stated | SEC |
| Aug 9, 2022 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 47,477 | $554k | 11.2% | Unusual | SEC |
| Aug 1, 2022 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 23,229 | $264k | 3.0% | Plan not stated | SEC |
| Jun 30, 2022 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 19,959 | $231k | 2.5% | Plan not stated | SEC |
| Jun 14, 2022 | Kessler Marla L | Director | Form 4 sale | 7,610 | $89k | 8.3% | Plan not stated | SEC |
| Jun 7, 2022 | Currie Mark G | Director | Form 4 sale | 190,383 | $2.3M | 24.3% | Plan not stated | SEC |
| May 23, 2022 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 36,308 | $418k | 4.3% | Plan not stated | SEC |
| May 23, 2022 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 120 | $1k | 0.1% | Plan not stated | SEC |
| May 23, 2022 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 10,583 | $122k | 3.8% | Plan not stated | SEC |
| May 23, 2022 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 13,537 | $156k | 3.2% | Plan not stated | SEC |
| Mar 24, 2022 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 3,031 | $39k | 2.8% | Plan not stated | SEC |
| Mar 14, 2022 | McHugh Julie | Director | Form 4 sale | 20,000 | $233k | 14.5% | Plan not stated | SEC |
| Feb 28, 2022 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 2,238 | $24k | 3.5% | Plan not stated | SEC |
| Feb 28, 2022 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 48,424 | $522k | 7.6% | Unusual | SEC |
| Feb 28, 2022 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 17,607 | $190k | 8.3% | Unusual | SEC |
| Feb 28, 2022 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 28,962 | $312k | 8.1% | Unusual | SEC |
| Dec 22, 2021 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 46,327 | $529k | 7.5% | Unusual | SEC |
| Dec 16, 2021 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 27,000 | $305k | 7.8% | Unusual | SEC |
| Dec 14, 2021 | McHugh Julie | Director | Form 4 sale | 10,000 | $110k | 6.7% | Plan not stated | SEC |
| Nov 23, 2021 | MCCOURT Thomas A | Chief Executive Officer | Form 4 sale | 52,644 | $610k | 7.8% | Unusual | SEC |
| Nov 23, 2021 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 17,193 | $199k | 4.8% | Unusual | SEC |
| Nov 23, 2021 | Shetzline Michael | CMO,SVP,Head-Res&Drug | Form 4 sale | 13,776 | $160k | 7.0% | Plan not stated | SEC |
| Nov 23, 2021 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 1,462 | $17k | 2.3% | Plan not stated | SEC |
| Aug 16, 2021 | Silver Ronald | Principal Accounting Officer | Form 4 sale | 567 | $8k | 0.9% | Plan not stated | SEC |
| Aug 16, 2021 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 680 | $9k | 0.2% | Plan not stated | SEC |
| Jun 14, 2021 | Currie Mark G | Director | Form 4 sale | 23,571 | $273k | 4.0% | Plan not stated | SEC |
| May 24, 2021 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Form 4 sale | 2,077 | $25k | 1.0% | Plan not stated | SEC |
| May 24, 2021 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 516 | $6k | 0.1% | Plan not stated | SEC |
| May 24, 2021 | MCCOURT Thomas A | President and Interim CEO | Form 4 sale | 1,716 | $21k | 0.3% | Plan not stated | SEC |
| Feb 26, 2021 | Shetzline Michael | CMO, SVP & Head of Drug Devt. | Form 4 sale | 4,439 | $40k | 2.7% | Plan not stated | SEC |
| Feb 26, 2021 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 13,651 | $124k | 4.3% | Unusual | SEC |
| Feb 26, 2021 | MCCOURT Thomas A | President | Form 4 sale | 14,685 | $134k | 3.0% | Unusual | SEC |
| Feb 26, 2021 | Mallon Mark | Chief Executive Officer | Form 4 sale | 30,675 | $279k | 6.1% | Plan not stated | SEC |
| Feb 26, 2021 | Kilroy Conor | SVP, GC & Secretary | Form 4 sale | 6,989 | $64k | 5.4% | Plan not stated | SEC |
| Feb 26, 2021 | Consylman Gina | SVP, CFO & Treasurer | Form 4 sale | 18,406 | $168k | 5.2% | Unusual | SEC |
| Dec 4, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 5,639 | $70k | 5.7% | Plan not stated | SEC |
| Nov 11, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 3,561 | $42k | 3.7% | Plan not stated | SEC |
| Nov 9, 2020 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 394 | $4k | 0.2% | Plan not stated | SEC |
| Nov 9, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 2,797 | $31k | 2.9% | Plan not stated | SEC |
| Nov 9, 2020 | Kilroy Conor | SVP, GC & Secretary | Form 4 sale | 836 | $9k | 0.6% | Plan not stated | SEC |
| Nov 9, 2020 | Consylman Gina | SVP, CFO & Treasurer | Form 4 sale | 1,415 | $15k | 0.5% | Plan not stated | SEC |
| Oct 8, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 22,714 | $238k | 19.2% | Unusual | SEC |
| Sep 8, 2020 | McHugh Julie | Director | Form 4 sale | 7,950 | $78k | 6.1% | Unusual | SEC |
| Aug 17, 2020 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 689 | $7k | 0.3% | Plan not stated | SEC |
| Aug 17, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 575 | $6k | 0.5% | Plan not stated | SEC |
| Jun 10, 2020 | Olanoff Lawrence S | Director | Form 4 sale | 11,350 | $114k | 14.2% | Unusual | SEC |
| May 11, 2020 | Rickard Jason | SVP, Chief Operating Officer | Form 4 sale | 510 | $5k | 0.2% | Plan not stated | SEC |
| May 11, 2020 | MCCOURT Thomas A | President | Form 4 sale | 1,697 | $18k | 0.5% | Plan not stated | SEC |
| May 11, 2020 | Mallon Mark | Chief Executive Officer | Form 4 sale | 23,206 | $240k | 4.4% | Plan not stated | SEC |
| May 11, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 1,153 | $12k | 1.0% | Plan not stated | SEC |
| May 11, 2020 | Kilroy Conor | SVP, GC & Secretary | Form 4 sale | 716 | $7k | 0.6% | Plan not stated | SEC |
| Feb 24, 2020 | Mallon Mark | Chief Executive Officer | Form 4 sale | 7,984 | $93k | 2.6% | Plan not stated | SEC |
| Feb 21, 2020 | MCCOURT Thomas A | President | Form 4 sale | 4,177 | $49k | 1.9% | Plan not stated | SEC |
| Feb 21, 2020 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 3,900 | $45k | 4.5% | Plan not stated | SEC |
| Feb 21, 2020 | Gilbert Halley E | Chief Admin Officer & SVP | Form 4 sale | 15,328 | $178k | 5.4% | Plan not stated | SEC |
| Feb 21, 2020 | Consylman Gina | SVP, CFO & Treasurer | Form 4 sale | 12,501 | $145k | 5.8% | Unusual | SEC |
| Jan 31, 2020 | Gilbert Halley E | Chief Admin Officer & SVP | Form 4 sale | 60,000 | $723k | 17.6% | Unusual | SEC |
| Jan 24, 2020 | MCCOURT Thomas A | President | Form 4 sale | 20,000 | $254k | 8.2% | Unusual | SEC |
| Jan 23, 2020 | Currie Mark G | Director | Form 4 sale | 60,000 | $755k | 9.8% | Plan not stated | SEC |
| Jan 16, 2020 | Currie Mark G | Director | Form 4 sale | 8,888 | $114k | 1.6% | Plan not stated | SEC |
| Nov 8, 2019 | MacDonald Kelly | Chief Accounting Officer | Form 4 sale | 987 | $11k | 1.2% | Plan not stated | SEC |
| Nov 8, 2019 | Consylman Gina | SVP, CFO & Treasurer | Form 4 sale | 1,510 | $17k | 0.9% | Plan not stated | SEC |
| Aug 30, 2019 | MCCOURT Thomas A | President | Form 4 sale | 220,000 | $2M | 66.7% | Unusual | SEC |
| Aug 16, 2019 | Consylman Gina | SVP, CFO & Treasurer | Form 4 sale | 212 | $2k | 0.1% | Plan not stated | SEC |
| Jul 26, 2019 | Gilbert Halley E | Chief Admin Officer & SVP | Form 4 sale | 20,000 | $200k | 7.7% | Plan not stated | SEC |
| Jun 5, 2019 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $23k | 3.3% | Plan not stated | SEC |
| Jun 5, 2019 | McHugh Julie | Director | Form 4 sale | 1,500 | $17k | 1.4% | Plan not stated | SEC |
| May 10, 2019 | MCCOURT Thomas A | President | Form 4 sale | 4,055 | $43k | 3.6% | Plan not stated | SEC |
| May 10, 2019 | Gilbert Halley E | Chief Admin Officer & SVP | Form 4 sale | 4,055 | $43k | 1.7% | Plan not stated | SEC |
| May 10, 2019 | Currie Mark G | Director | Form 4 sale | 4,055 | $43k | 0.8% | Plan not stated | SEC |
| May 10, 2019 | Consylman Gina | SVP, CFO & Treasurer | Form 4 sale | 4,055 | $43k | 2.3% | Unusual | SEC |
| Mar 8, 2019 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 275,000 | $3.6M | 34.2% | Unusual | SEC |
| Mar 5, 2019 | McHugh Julie | Director | Form 4 sale | 1,500 | $22k | 1.7% | Plan not stated | SEC |
| Mar 5, 2019 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $29k | 5.1% | Plan not stated | SEC |
| Feb 21, 2019 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 4,841 | $69k | 5.5% | Plan not stated | SEC |
| Feb 21, 2019 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 10,242 | $147k | 4.4% | Plan not stated | SEC |
| Feb 21, 2019 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 1,644 | $24k | 0.2% | Plan not stated | SEC |
| Feb 21, 2019 | Consylman Gina | Chief Financial Officer | Form 4 sale | 5,677 | $81k | 3.4% | Unusual | SEC |
| Jan 25, 2019 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 89,551 | $1.1M | 1.9% | Plan not stated | SEC |
| Dec 6, 2018 | McHugh Julie | Director | Form 4 sale | 1,500 | $19k | 1.6% | Plan not stated | SEC |
| Dec 6, 2018 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $25k | 4.8% | Plan not stated | SEC |
| Nov 9, 2018 | Consylman Gina | Chief Financial Officer | Form 4 sale | 1,358 | $16k | 1.4% | Plan not stated | SEC |
| Oct 5, 2018 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 233,301 | $4.2M | 88.6% | Unusual | SEC |
| Sep 5, 2018 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $38k | 4.6% | Plan not stated | SEC |
| Sep 5, 2018 | McHugh Julie | Director | Form 4 sale | 1,500 | $29k | 1.6% | Plan not stated | SEC |
| Aug 24, 2018 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 65,000 | $1.2M | 7.7% | Plan not stated | SEC |
| Aug 23, 2018 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 130,000 | $2.4M | 14.4% | Unusual | SEC |
| Aug 17, 2018 | Consylman Gina | Chief Financial Officer | Form 4 sale | 188 | $3k | 0.2% | Plan not stated | SEC |
| Jul 6, 2018 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 30,000 | $600k | 100.0% | Unusual | SEC |
| Jul 3, 2018 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 29,551 | $584k | 100.0% | Unusual | SEC |
| Jun 5, 2018 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $35k | 4.4% | Plan not stated | SEC |
| Jun 5, 2018 | McHugh Julie | Director | Form 4 sale | 1,500 | $26k | 1.6% | Plan not stated | SEC |
| Mar 5, 2018 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $28k | 6.4% | Plan not stated | SEC |
| Mar 5, 2018 | McHugh Julie | Director | Form 4 sale | 1,500 | $21k | 1.9% | Plan not stated | SEC |
| Feb 21, 2018 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 1,634 | $24k | 8.3% | Plan not stated | SEC |
| Feb 21, 2018 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 3,343 | $49k | 6.0% | Plan not stated | SEC |
| Feb 21, 2018 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 7,741 | $113k | 7.6% | Plan not stated | SEC |
| Feb 21, 2018 | Consylman Gina | Chief Financial Officer | Form 4 sale | 3,594 | $53k | 6.0% | Unusual | SEC |
| Jan 24, 2018 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 60,000 | $927k | 7.2% | Plan not stated | SEC |
| Dec 7, 2017 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 113,405 | $1.7M | 2.4% | Plan not stated | SEC |
| Dec 4, 2017 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $33k | 6.0% | Plan not stated | SEC |
| Dec 4, 2017 | McHugh Julie | Director | Form 4 sale | 1,500 | $25k | 1.9% | Plan not stated | SEC |
| Nov 10, 2017 | Consylman Gina | Interim CFO and CAO | Form 4 sale | 864 | $13k | 1.6% | Plan not stated | SEC |
| Sep 5, 2017 | Olanoff Lawrence S | Director | Form 4 sale | 2,000 | $32k | 5.7% | Plan not stated | SEC |
| Sep 5, 2017 | McHugh Julie | Director | Form 4 sale | 1,500 | $24k | 1.8% | Plan not stated | SEC |
| Aug 18, 2017 | Consylman Gina | Chief Accounting Officer | Form 4 sale | 207 | $3k | 0.4% | Plan not stated | SEC |
| Jun 22, 2017 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 35,000 | $691k | 100.0% | Unusual | SEC |
| Jun 8, 2017 | Olanoff Lawrence S | Director | Form 4 sale | 3,200 | $57k | 8.3% | Plan not stated | SEC |
| May 15, 2017 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 30,000 | $546k | 100.0% | Unusual | SEC |
| Mar 14, 2017 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 60,000 | $1M | 7.2% | Plan not stated | SEC |
| Mar 3, 2017 | Olanoff Lawrence S | Director | Form 4 sale | 3,200 | $55k | 12.3% | Plan not stated | SEC |
| Feb 24, 2017 | Consylman Gina | Chief Accounting Officer | Form 4 sale | 2,962 | $49k | 9.9% | Unusual | SEC |
| Feb 22, 2017 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 1,800 | $30k | 7.8% | Plan not stated | SEC |
| Feb 22, 2017 | Graney Thomas | Chief Financial Officer | Form 4 sale | 1,874 | $32k | 8.3% | Plan not stated | SEC |
| Feb 22, 2017 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 1,520 | $26k | 5.1% | Plan not stated | SEC |
| Feb 22, 2017 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 5,039 | $85k | 7.7% | Plan not stated | SEC |
| Feb 22, 2017 | Consylman Gina | Chief Accounting Officer | Form 4 sale | 1,839 | $31k | 5.8% | Plan not stated | SEC |
| Feb 14, 2017 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 37,385 | $626k | 100.0% | Unusual | SEC |
| Jan 12, 2017 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 65,987 | $1M | 1.4% | Plan not stated | SEC |
| Dec 5, 2016 | Olanoff Lawrence S | Director | Form 4 sale | 3,200 | $50k | 10.9% | Plan not stated | SEC |
| Nov 11, 2016 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 14,000 | $235k | 100.0% | Unusual | SEC |
| Sep 6, 2016 | Olanoff Lawrence S | Director | Form 4 sale | 3,200 | $44k | 9.8% | Plan not stated | SEC |
| Aug 19, 2016 | Consylman Gina | Chief Accounting Officer | Form 4 sale | 207 | $3k | 1.0% | Plan not stated | SEC |
| Jun 3, 2016 | Olanoff Lawrence S | Director | Form 4 sale | 2,200 | $28k | 6.3% | Plan not stated | SEC |
| May 25, 2016 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 20,275 | $247k | 23.9% | Plan not stated | SEC |
| Mar 11, 2016 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 120,000 | $1.3M | 2.5% | Plan not stated | SEC |
| Mar 9, 2016 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 150,000 | $1.6M | 28.6% | Unusual | SEC |
| Mar 7, 2016 | Olanoff Lawrence S | Director | Form 4 sale | 2,200 | $24k | 16.6% | Plan not stated | SEC |
| Feb 24, 2016 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 1,600 | $14k | 5.5% | Plan not stated | SEC |
| Feb 24, 2016 | Graney Thomas | Chief Financial Officer | Form 4 sale | 563 | $5k | 9.9% | Plan not stated | SEC |
| Feb 24, 2016 | Consylman Gina | Chief Accounting Officer | Form 4 sale | 420 | $4k | 6.2% | Plan not stated | SEC |
| Feb 24, 2016 | Gilbert Halley E | Chief Legal Officer | Form 4 sale | 2,778 | $24k | 7.1% | Plan not stated | SEC |
| Feb 24, 2016 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 152,154 | $1.3M | 28.9% | Unusual | SEC |
| Dec 15, 2015 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 73,418 | $813k | 100.0% | Unusual | SEC |
| Dec 7, 2015 | Olanoff Lawrence S | Director | Form 4 sale | 2,200 | $26k | 14.3% | Plan not stated | SEC |
| Sep 4, 2015 | Olanoff Lawrence S | Director | Form 4 sale | 3,725 | $41k | 19.4% | Plan not stated | SEC |
| Mar 18, 2015 | Fanucci Marsha | Director | Form 4 sale | 31,339 | $491k | 61.3% | Unusual | SEC |
| Mar 17, 2015 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 200,000 | $3.1M | 4.6% | Plan not stated | SEC |
| Mar 12, 2015 | Cook Joseph C Jr | Director | Form 4 sale | 5,883 | $91k | 1.9% | Unusual | SEC |
| Mar 10, 2015 | Roberts Bryan E | Director | Form 4 sale | 95,998 | $1.5M | 100.0% | Unusual | SEC |
| Mar 3, 2015 | Hecht Peter M | Chief Executive Officer | Form 4 sale | 63,442 | $999k | 1.5% | Plan not stated | SEC |
| Feb 20, 2015 | Cook Joseph C Jr | Director | Form 4 sale | 35,500 | $554k | 43.3% | Unusual | SEC |
| Feb 19, 2015 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 25,000 | $392k | 7.5% | Plan not stated | SEC |
| Dec 16, 2014 | Higgins Michael J | Chief Operating Officer | Form 4 sale | 15,987 | $224k | 5.1% | Plan not stated | SEC |
| Dec 15, 2014 | Roberts Bryan E | Director | Form 4 sale | 19,792 | $301k | 54.5% | Unusual | SEC |
| Dec 11, 2014 | Cook Joseph C Jr | Director | Form 4 sale | 100 | $2k | 0.1% | Plan not stated | SEC |
| Nov 24, 2014 | Higgins Michael J | Chief Operating Officer | Form 4 sale | 70,898 | $975k | 19.1% | Plan not stated | SEC |
| Nov 13, 2014 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 20,000 | $273k | 6.1% | Plan not stated | SEC |
| Jun 16, 2014 | Cook Joseph C Jr | Director | Form 4 sale | 600 | $9k | 0.9% | Plan not stated | SEC |
| Jun 12, 2014 | Roberts Bryan E | Director | Form 4 sale | 200,000 | $2.8M | 100.0% | Unusual | SEC |
| Jun 9, 2014 | Roberts Bryan E | Director | Form 4 sale | 288,846 | $4.2M | 90.1% | Unusual | SEC |
| May 30, 2014 | Roberts Bryan E | Director | Form 4 sale | 411,154 | $6M | 84.1% | Unusual | SEC |
| May 29, 2014 | Higgins Michael J | Chief Operating Officer | Form 4 sale | 50,000 | $728k | 100.0% | Unusual | SEC |
| May 22, 2014 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 25,000 | $348k | 7.5% | Plan not stated | SEC |
| Apr 24, 2014 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 25,000 | $292k | 7.5% | Plan not stated | SEC |
| Feb 18, 2014 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 15,000 | $216k | 4.6% | Plan not stated | SEC |
| Jan 23, 2014 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 20,000 | $288k | 6.1% | Plan not stated | SEC |
| Jan 14, 2014 | Roberts Bryan E | Director | Form 4 sale | 21,200 | $266k | 12.9% | Plan not stated | SEC |
| Jan 13, 2014 | Roberts Bryan E | Director | Form 4 sale | 823,350 | $10.5M | 84.9% | Unusual | SEC |
| Jan 6, 2014 | Roberts Bryan E | Director | Form 4 sale | 55,450 | $666k | 16.6% | Plan not stated | SEC |
| Nov 7, 2013 | Mcguire Terrance | Director | Form 4 sale | 2,083 | $19k | 100.0% | Unusual | SEC |
| Jun 17, 2013 | Higgins Michael J | Chief Operating Officer | Form 4 sale | 150,000 | $1.8M | 36.0% | Unusual | SEC |
| Mar 28, 2013 | FIL Ltd | 10% owner | Form 4 sale | 158,068 | $2.9M | 15.9% | Plan not stated | SEC |
| Mar 21, 2013 | Fmr LLC | 10% owner | Form 4 sale | 240,100 | 19.4% | Unusual | SEC | |
| Mar 11, 2013 | MCCOURT Thomas A | Chief Commercial Officer | Form 4 sale | 40,000 | $680k | 100.0% | Unusual | SEC |
| Mar 5, 2013 | Higgins Michael J | Chief Operating Officer | Form 4 sale | 50,000 | $779k | 26.1% | Unusual | SEC |
| Oct 15, 2012 | FIL Ltd | 10% owner | Form 4 sale | 212,875 | $2.8M | 14.7% | Unusual | SEC |
| Oct 8, 2012 | Fmr LLC | 10% owner | Form 4 sale | 19,305 | $251k | 1.3% | Plan not stated | SEC |
| Oct 3, 2012 | FIL Ltd | 10% owner | Form 4 sale | 8,400 | $109k | 0.6% | Plan not stated | SEC |
| Sep 27, 2012 | Fmr LLC | 10% owner | Form 4 sale | 94,695 | $1.3M | 6.0% | Unusual | SEC |
| Sep 25, 2012 | FIL Ltd | 10% owner | Form 4 sale | 235,686 | $3.4M | 13.0% | Unusual | SEC |
| Sep 20, 2012 | Fmr LLC | 10% owner | Form 4 sale | 158,333 | $2.1M | 8.1% | Unusual | SEC |
| Sep 17, 2012 | FIL Ltd | 10% owner | Form 4 sale | 153,776 | $2M | 7.3% | Plan not stated | SEC |
| Aug 30, 2012 | Fmr LLC | 10% owner | Form 4 sale | 24,100 | $317k | 1.1% | Plan not stated | SEC |
| Jul 31, 2012 | Fmr LLC | 10% owner | Form 4 sale | 7,445 | $98k | 0.3% | Plan not stated | SEC |
| Jul 27, 2012 | Fmr LLC | 10% owner | Form 4 sale | 58,880 | $782k | 2.7% | Plan not stated | SEC |
| Jul 24, 2012 | Fmr LLC | 10% owner | Form 4 sale | 22,940 | $300k | 1.0% | Plan not stated | SEC |
| Jul 19, 2012 | Fmr LLC | 10% owner | Form 4 sale | 73,215 | $981k | 3.2% | Plan not stated | SEC |
| Jul 16, 2012 | Fmr LLC | 10% owner | Form 4 sale | 35,313 | $487k | 1.5% | Plan not stated | SEC |
| Jul 10, 2012 | Fmr LLC | 10% owner | Form 4 sale | 18,955 | $261k | 0.8% | Plan not stated | SEC |
| Jul 6, 2012 | FIL Ltd | 10% owner | Form 4 sale | 44,417 | $620k | 1.8% | Plan not stated | SEC |
| Jul 2, 2012 | FIL Ltd | 10% owner | Form 4 sale | 56,574 | $782k | 2.3% | Plan not stated | SEC |
| Feb 6, 2012 | Ridgeback Capital Management LP | 10% owner | Form 4 sale | 112,478 | $1.7M | 1.6% | Plan not stated | SEC |
| Jun 24, 2011 | Higgins Michael J | Chief Operating Officer | Form 4 sale | 25,000 | $399k | 16.7% | Plan not stated | SEC |
| Jun 23, 2011 | Ridgeback Capital Investments L.P. | 10% owner | Form 4 sale | 500,000 | $8.1M | 4.8% | Plan not stated | SEC |
| Apr 21, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 20,000 | $303k | 8.7% | Plan not stated | SEC |
| Apr 14, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 15,137 | $227k | 6.7% | Plan not stated | SEC |
| Apr 13, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 24,863 | $373k | 10.6% | Plan not stated | SEC |
| Mar 21, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 40,000 | $528k | 16.0% | Unusual | SEC |
| Mar 3, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 7,721 | $97k | 3.5% | Plan not stated | SEC |
| Feb 28, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 2,279 | $28k | 1.1% | Plan not stated | SEC |
| Feb 23, 2011 | Currie Mark G | Chief Scientific Officer | Form 4 sale | 30,000 | $357k | 12.5% | Plan not stated | SEC |